| Dec 06 | Dec 05 | Dec 04 | Dec 03 | Dec 02 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | - | - | - | $ 575.37K | $ 421.02K |
| Operating Income | $ -268.05K | $ -340.21K | $ -134.61K | $ 73.00 | $ -431.47K |
| EBITDA | $ -268.05K | $ -340.21K | $ -103.20K | $ 288.22K | $ -410.79K |
| Net Income | $ -268.05K | $ 36.53K | $ -581.37K | $ -288.44K | $ -640.67K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 0.00 | $ 2.53K | $ 54.92K | $ 586.14K | $ 967.26K |
| Total Debt | $ 262.78K | $ 0.00 | $ 0.00 | $ 282.46K | $ 683.85K |
| Net Debt | $ 262.78K | $ -2.53K | $ -14.08K | $ -165.53K | $ 604.18K |
| Total Liabilities | $ 475.07K | $ 209.55K | $ 441.47K | $ 644.25K | $ 1.20M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -2.53K | $ -25.65K | $ -419.15K | $ 365.84K | $ -464.36K |
| Operating Cash Flow | $ -2.53K | $ -25.65K | $ -416.71K | $ 366.05K | $ -453.25K |
| Investing Cash Flow | |||||
| Financing Cash Flow |
UniverCell Holdings Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.